NVCR - Latest News

Novocure Ltd (NVCR), operates in Healthcare / Medical - Devices, trades on NASDAQ.

Market capitalization stands near $1.67B. Beta to the broader market is 0.99.

The article list below shows the most recent NVCR headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent NVCR Headlines

Novocure: A Mispriced Cash-Generating Biotech With Upside Potential

seekingalpha.com - Oct 13, 2026

NovoCure is undervalued at a $1. 66B market cap, with its pipeline and FDA-approved products not fully reflected in its price.

Reviewing NeurAxis (NASDAQ:NRXS) and NovoCure (NASDAQ:NVCR)

defenseworld.net - Oct 12, 2026

NeurAxis (NASDAQ: NRXS - Get Free Report) and NovoCure (NASDAQ: NVCR - Get Free Report) are both small-cap healthcare companies, but which is the bett

Critical Survey: Medline (NASDAQ:MDLN) & NovoCure (NASDAQ:NVCR)

defenseworld.net - Oct 11, 2026

NovoCure (NASDAQ: NVCR - Get Free Report) and Medline (NASDAQ: MDLN - Get Free Report) are both healthcare companies, but which is the superior stock?

Novocure's Optune Pax® Receives Approval in Japan for the Treatment of Unresectable Locally Advanced Pancreatic Cancer

businesswire.com - Oct 1, 2026

BAAR, Switzerland--(BUSINESS WIRE)--Novocure (Nasdaq: NVCR) announced today that Japan's Ministry of Health, Labour and Welfare (MHLW) approved Optune

NovoCure Limited $NVCR Stake Trimmed by Corient Private Wealth LP

defenseworld.net - Sep 28, 2026

Corient Private Wealth LP lessened its holdings in NovoCure Limited (NASDAQ: NVCR) by 71. 5% in the undefined quarter, according to its most recent 13

How News Affects NVCR Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track NVCR's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked NVCR news questions

What is the latest NVCR news headline?

The most recent NVCR headline (Oct 13, 2026) is "Novocure: A Mispriced Cash-Generating Biotech With Upside Potential". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the NVCR news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What NVCR news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual NVCR options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.